Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05712278
What this trial is testing

Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukaemia
Sanofi 7
Early research (Phase 1)Not Yet RecruitingNCT07367685
What this trial is testing

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Recurrent/Refractory B-cell Lymphoma
The Second Affiliated Hospital of Fujian Medical University 6
Early research (Phase 1)Ended earlyNCT03220347
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 139
Large-scale testing (Phase 3)Study completedNCT00668343
What this trial is testing

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Tehran University of Medical Sciences 80
Testing effectiveness (Phase 2)Study completedNCT01138904
What this trial is testing

FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Cancer
Dong-A University Hospital 80
Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Early research (Phase 1)Active Not RecruitingNCT05878184
What this trial is testing

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

Who this might be right for
Non Hodgkin LymphomaChronic Lymphocytic Leukemia
Sana Biotechnology 16
Early research (Phase 1)Study completedNCT03013933
What this trial is testing

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 29
Not applicableEnded earlyNCT01517347
What this trial is testing

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 90
Testing effectiveness (Phase 2)Study completedNCT03439293
What this trial is testing

Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
Takeda 61
Testing effectiveness (Phase 2)WithdrawnNCT00845104
What this trial is testing

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)UnknownNCT03940833
What this trial is testing

Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM

Who this might be right for
Multiple Myeloma
Asclepius Technology Company Group (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752
What this trial is testing

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia
Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00866138
What this trial is testing

Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3

Who this might be right for
Multiple Myeloma
AB Science 24
Early research (Phase 1)Looking for participantsNCT06191978
What this trial is testing

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Not applicableUnknownNCT01710085
What this trial is testing

Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients

Who this might be right for
Cervical CancerEndometrial Cancer
Uludag University 100
Testing effectiveness (Phase 2)Study completedNCT02927964
What this trial is testing

TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma

Who this might be right for
Grade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+4 more
Robert Lowsky 21
Early research (Phase 1)Ended earlyNCT06163898
What this trial is testing

Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 4
Large-scale testing (Phase 3)Study completedNCT00117598
What this trial is testing

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Who this might be right for
Lymphoma
Pfizer 169
Testing effectiveness (Phase 2)Study completedNCT01253447
What this trial is testing

AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
National Cancer Institute (NCI) 19
Next Page